1. Home
  2. FWRD vs STRO Comparison

FWRD vs STRO Comparison

Compare FWRD & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Air Corporation

FWRD

Forward Air Corporation

HOLD

Current Price

$15.97

Market Cap

428.5M

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$22.88

Market Cap

507.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWRD
STRO
Founded
1981
2003
Country
United States
United States
Employees
N/A
133
Industry
Oil Refining/Marketing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
428.5M
507.6M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
FWRD
STRO
Price
$15.97
$22.88
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$37.50
$31.33
AVG Volume (30 Days)
1.1M
439.0K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
88.54
N/A
EPS
N/A
N/A
Revenue
$1,269,573,000.00
N/A
Revenue This Year
$6.57
N/A
Revenue Next Year
$6.66
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.86
$0.72
52 Week High
$32.47
$43.85

Technical Indicators

Market Signals
Indicator
FWRD
STRO
Relative Strength Index (RSI) 65.33 32.68
Support Level $15.28 $19.11
Resistance Level $23.55 $27.96
Average True Range (ATR) 1.04 2.29
MACD 0.16 -0.86
Stochastic Oscillator 97.44 5.57

Price Performance

Historical Comparison
FWRD
STRO

About FWRD Forward Air Corporation

Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in North and South America, Europe, and Asia.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: